Involvement of caspase family proteases in transforming growth factor- β-induced apoptosis

Cell Growth and Differentiation

Volumn 8, Issue 7, 1997, Pages 821-827

  Chen, Ruey Hwa ^a   Chang, Tien Yun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SUBSTRATE; GENE CONTROL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASES; COWPOX VIRUS; CYCLINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; HUMANS; LIVER NEOPLASMS; NUCLEAR PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SERPINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

COWPOX VIRUS;

EID: 0030752438     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. White, E. Life, death, and the pursuit of apoptosis. Genes Dev., 10: 1-15, 1996.
2. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell, 75: 641-652, 1993.
3. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., and Yuan, J. Y. Human ICE/CED-3 protease nomenclature. Cell, 87: 171, 1996.
4. Whyte, M. ICE/CED-3 proteases in apoptosis. Trends Cell Biol., 6: 245-248, 1996.
5. Ellis, H. M., and Horvitz, H. R. Genetic control of programmed cell death in the nematode C. elegans. Cell, 44: 817-829, 1986.
6. Hengartner, M. O., Ellis, R. E., and Horvitz, H. R. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature (Lond.), 356: 494-499, 1992.
7. Troy, C. M., Stefanis, L., Prochiantz, A., Greene, L. A., and Shelanski, M. L. The contrasting roles of ICE family proteases and interleukin-1β in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc. Natl. Acad. Sci. USA, 93: 5635-5640, 1996.
8. Enari, M., Hug, H., and Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.), 375: 78-81, 1995.
9. Enari, M., Talanian, R. V., Wong, W. W., and Nagata, S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.), 380: 723-726, 1996.
10. Gagliardini, V., Fernandez, P-A., Lee, R. K. K., Drexler, H. C. A., Rotello, R. J., Fishman, M. C., and Yuan, J. Prevention of vertebrate neuronal death by the crmA gene. Science (Washington DC), 263: 826-828, 1994.
11. Los, M., Van de Craen, M., Penning, L. C., Shenk, H., Westendorp, M., Baeuerle, P. A., Droge, W., Krammer, P. H., Fiers, W., and Schulze-Osthoff, K. Requirement of an ICE/Ced-3 protease for Fas/APO-1-mediated apoptosis. Nature (Lond.), 375: 81-83, 1995.
12. Miura, M., Friedlander, R. M., and Yuan, J. Y. Tumor necrosis factor-induced apoptosis is mediated by a crmA-sensitive cell death pathway. Proc. Natl. Acad. Sci. USA, 92: 8318-8322, 1995.
13. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T-T., Yu, V. L., and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
14. Tewari, M., and Dixit, V. M. Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem., 270: 3255-3260, 1995.
15. Fernandes-Alnemri, T., Takahashi, A., Armstrong, R., Krebs, J., Fritz, L., Tomaselli, K. J., Wang, L., Yu, Z., Croce, C. M., Salvesen, G., Earnshaw, W., Litwack, G., and Alnemri, E. S. Mch3, a novel human apoptotic cysteine protease highly related to cpp32. Cancer Res., 55: 6045-6052, 1995.
16. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. Mch2, a new member of the apoptotic ced-3/Ice cysteine protease gene family. Cancer Res., 55: 2737-2742, 1995.
17. Tewari, M., Ouan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. Yama/ CPP32β, a mammalian homolog of CED-3, is a crmA inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
18. Song, Q., Lees-Miller, S. P., Kumar, S., Zhang, N., Chan, D. W., Smith, G. C. M., Jackson, S. P., Alnemri, E. S., Litwack, G., Khanna, K. K., and Lavin, M. F. DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J., 15: 3238-3246, 1996.
19. Kingsley, D. M. The TGF-β superfamily: new members, new receptors and new genetic tests of function in different organisms. Gene Dev., 8: 133-146, 1994.
20. Derynck, R. Transforming growth factor-β. In: A. W. Thomson (ed.), The Cytokine Handbook, pp. 319-342. San Diego: Academic Press, 1994.
21. Massagué, J., Attisano, L., and Wrana, J. L. The TGF-β family and its composite receptors. Trends Cell Biol., 4: 172-177, 1994.
22. Selvakumaran, M., Lin, H-K., Sjin, R. T., Reed, J. C., Lieberman, D. A., and Hoffman, B. The novel primary response gene Myd118 and the protooncogenes myb, myc and bcl-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukemia cells. Mol. Cell. Biol., 14: 2352-2360, 1994.
23. Rotello, R. J., Liebermann, R. C., Purchio, A. F., and Gerschenson, L. E. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor-β1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA, 88: 3412-3415, 1991.
24. Yanagihara, K., and Tsumuraya, M. Transforming growth factor β-1 induces apoptotic cell death of cultured human gastric carcinoma cells. Cancer Res., 52: 4042-4045, 1992.
25. Wang, C. Y., Eshleman, J. R., Wilson, J. K. V., and Markowitz, S. Both transforming growth factor-β and substrate release are inducers of apoptosis in a human colon adenoma cell line. Cancer Res., 55: 5101-5105, 1995.
26. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-beta1. Proc. Natl. Acad. Sci. USA, 89: 5408-5412, 1992.
27. Fukuda, K., Kojiro, M., and Chiu, J-F. Induction of apoptosis by transforming growth factor-β1 in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Hepatology, 18: 945-952, 1993.
28. Lin, J-K., and Chou, C-K. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res., 52: 385-388, 1992.
29. Chuang, L-Y., Hung, W-C., Chang, C-C., and Tsai, J-H. Characterization of apoptosis induced by transforming growth factor β1 in human hepatoma cells. Anticancer Res., 14: 147-152, 1994.
30. Gavrieli, Y., Sheman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
31. Keeton, M. R., Cumden, S. A., van Zonneveld, A., and Lostutoff, D. J. Identification of regulatory sequences in the type I plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem., 266: 23048-23052, 1991.
32. Feng, X-H., Filvaroff, E. H., and Derynck, R. Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J. Biol. Chem., 270: 24237-24245, 1995.
33. Jacobson, M. D., Weil, M., and Raff, M. C. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell Biol., 133: 1041-1051, 1996.
34. Smith, K. G., Strasser, A., and Vaux, D. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J., 15: 5167-5176, 1996.
35. Muzio, M., Salvesen, G. S., and Dixit, V. M. FLICE induced apoptosis in a cell-free system. J. Biol. Chem., 272: 2952-2956, 1997.
36. Nagata, S. Apoptosis by death factor. Cell, 88: 355-365, 1997.
37. Rodriguez, I., Matsuura, K., Ody, C., Nagata, S., and Vassalli, P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med., 184: 2067-2072, 1996.
38. Tanaka, S., and Wands, J. R. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor β1-induced apoptosis. Cancer Res., 56: 391-394, 1996.
39. Fausto, N. Hepatocyte apoptosis: is transforming growth factor-β1 the kiss of death? Hepatology, 18: 1536-1537, 1993.
40. Rouguet, N., Pagegraves, J. C., Molina, T., Briand, P., and Joulin, V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr. Biol., 6: 1192-1195, 1996.
41. Esposito, J., Londit, R., and Obijeski, J. The preparation of orthopox virus DNA. J. Virol. Methods, 2: 175-179, 1981.